Antares Pharma, Inc. (ATRS) SEC filings
ATRS SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the ATRS overview →
No ATRS SEC filing events in the measured window.
Nothing matched in the current window — the ATRS overview has every event we measure for this name.
Get an email when ATRS moves on news →Keep exploring
More ATRS: earnings → · analyst actions → · ATRS overview →
Other Healthcare names and their SEC filings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| United Therapeutics Corporation (UTHR) | 964 | +0.03% | 52% |
| Natera, Inc. (NTRA) | 957 | +0.21% | 57% |
| Sage Therapeutics, Inc. (SAGE) | 951 | -0.14% | 41% |
| Geron Corporation (GERN) | 949 | -0.28% | 41% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its SEC filings — that is what the link opens.